Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer

Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer

Introduction: The treatment efficacy of prostate cancer (PCa) radiotherapy (RT) can be inadvertently affected by the concurrent usage of non-oncologic medications. Many studies have associated the intake of several non-oncologic drugs with cancer specific outcomes. In this study, we report the impac...

Full description

Saved in:
Bibliographic Details
Main Authors: Haley K. Perlow, Karishma Khullar, Ritesh Kumar, Sonya Sasmal, Kent Nakamoto, Yevgeniya Gokun, Jacob Eckstein, Rebekah Young, Dayssy A. Diaz, Douglas Martin, Katharine A. Collier, Lingbin Meng, Rahul R. Parikh, Steven Clinton, Shang-Jui Wang
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Current Oncology
Subjects:
prostate cancer
radiotherapy
metformin
aspirin
statin
Online Access:https://www.mdpi.com/1718-7729/32/6/353
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.mdpi.com/1718-7729/32/6/353

Similar Items